FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: LXX

  • Home
  •  | 
  • Tag Archives: "LXX"

Lexaria Bioscience Announces Beverage License Agreement with California-Based Cannabis Company

Lexaria Bioscience Announces Beverage License Agreement with California-Based Cannabis Company
April 24, 2019 - Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that it has entered a definitive 5-year agreement, via its subsidiary Lexaria CanPharm ULC, to provide Lexaria's patented DehydraTECHTM technology to a private California-based cannabis company for its utilization in certain cannabis-based beverages to be produced and sold in the states of California and Nevada.
Read more

Lexaria Bioscience Announces Partnership with Altria to Fund Research and Development of DehydraTECH(tm) Technology for Oral Nicotine

Lexaria Bioscience Announces Partnership with Altria to Fund Research and Development of DehydraTECH(tm) Technology for Oral Nicotine
January 15, 2019 - Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) ( "Lexaria Bioscience"), a drug delivery platform innovator, is pleased to announce that its wholly-owned subsidiary Lexaria Nicotine LLC ("Lexaria Nicotine") and Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc. (NYSE:MO) ("Altria"), have executed definitive agreements to pursue innovation in oral, reduced risk nicotine consumer products using Lexaria's patented DehydraTECH(TM) technology.
Read more